T helper 17 (Th17) cell responses to the gut microbiota in human diseases

Biomed Pharmacother. 2023 May:161:114483. doi: 10.1016/j.biopha.2023.114483. Epub 2023 Mar 10.

Abstract

The gut microbiota colonizing the gastrointestinal tract, is an indispensable "invisible organ" that affects multiple aspects of human health. The gut microbial community has been assumed to be an important stimulus to the immune homeostasis and development, and increasing data support the role of the gut microbiota-immunity axis in autoimmune diseases. Host's immune system requires recognition tools to communicate with the gut microbial evolutionary partners. Among these microbial perceptions, T cells enable the widest spectrum of gut microbial recognition resolution. Specific gut microbiota direct the induction and differentiation of Th17 cells in intestine. However, the detailed links between the gut microbiota and Th17 cells have not been well established. In this review, we describe the generation and characterization of Th17 cells. Notably, we discuss the induction and differentiation of Th17 cells by the gut microbiota and their metabolites, as well as recent advances in our understanding of interactions between Th17 cells and the gut microbiota in human diseases. In addition, we provide the emerging evidences in support of interventions targeting the gut microbes/Th17 cells in human diseases.

Keywords: Gut microbiota; Interactions, Immunity; Intervention targets; Th17 cells.

Publication types

  • Review

MeSH terms

  • Autoimmune Diseases / metabolism
  • Gastrointestinal Microbiome* / physiology
  • Gastrointestinal Tract
  • Humans
  • Microbiota
  • Th17 Cells*